1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2015

Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2015" provides an overview of Renal Dialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Renal Dialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Renal Dialysis Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Renal Dialysis Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Figures 5
1.2 List of Figures 10
2 Introduction 11
2.1 Renal Dialysis Equipment Overview 11
3 Products under Development 13
3.1 Renal Dialysis Equipment - Pipeline Products by Stage of Development 13
3.2 Renal Dialysis Equipment - Pipeline Products by Segment 14
3.3 Renal Dialysis Equipment - Pipeline Products by Territory 15
3.4 Renal Dialysis Equipment - Pipeline Products by Regulatory Path 16
3.5 Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 17
3.6 Renal Dialysis Equipment - Ongoing Clinical Trials 18
4 Renal Dialysis Equipment - Pipeline Products under Development by Companies 19
4.1 Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development 19
4.2 Renal Dialysis Equipment - Pipeline Products by Stage of Development 22
5 Renal Dialysis Equipment Companies and Product Overview 25
5.1 3S BioMedical, Inc. Company Overview 25
5.1.1 3S BioMedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
5.2 Advanced Dialysis Methods Ltd. Company Overview 26
5.2.1 Advanced Dialysis Methods Ltd. Pipeline Products and Ongoing Clinical Trials Overview 26
5.3 AngioDynamics, Inc. Company Overview 27
5.3.1 AngioDynamics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
5.4 ARISTE Medical Company Overview 29
5.4.1 ARISTE Medical Pipeline Products and Ongoing Clinical Trials Overview 29
5.5 Asahi Kasei Corporation Company Overview 31
5.5.1 Asahi Kasei Corporation Pipeline Products and Ongoing Clinical Trials Overview 31
5.6 Ash Access Technology, Inc. Company Overview 34
5.6.1 Ash Access Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
5.7 AWAK Technologies Pte Ltd Company Overview 36
5.7.1 AWAK Technologies Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview 36
5.8 Baxter International Inc. Company Overview 37
5.8.1 Baxter International Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
5.9 Blood Purification Technologies, Inc. Company Overview 46
5.9.1 Blood Purification Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 46
5.10 CatheNect Medical Company Overview 47
5.10.1 CatheNect Medical Pipeline Products and Ongoing Clinical Trials Overview 47
5.11 Chemica Technologies, Inc. Company Overview 48
5.11.1 Chemica Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
5.12 Chrysalis Medical Weight Loss Clinic Company Overview 49
5.12.1 Chrysalis Medical Weight Loss Clinic Pipeline Products and Ongoing Clinical Trials Overview 49
5.13 Circuport, Inc. Company Overview 50
5.13.1 Circuport, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
5.14 Control Medical Technology, LLC Company Overview 51
5.14.1 Control Medical Technology, LLC Pipeline Products and Ongoing Clinical Trials Overview 51
5.15 CreatiVasc Medical LLC Company Overview 52
5.15.1 CreatiVasc Medical LLC Pipeline Products and Ongoing Clinical Trials Overview 52
5.16 Cytograft Tissue Engineering, Inc. Company Overview 55
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
5.17 CytoPherx, Inc. Company Overview 57
5.17.1 CytoPherx, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
5.18 Debiotech S.A. Company Overview 58
5.18.1 Debiotech S.A. Pipeline Products and Ongoing Clinical Trials Overview 58
5.19 DEKA Research and Development Corporation Company Overview 62
5.19.1 DEKA Research and Development Corporation Pipeline Products and Ongoing Clinical Trials Overview 62
5.20 Dipylon Medical AB Company Overview 64
5.20.1 Dipylon Medical AB Pipeline Products and Ongoing Clinical Trials Overview 64
5.21 ExThera Medical LLC. Company Overview 67
5.21.1 ExThera Medical LLC. Pipeline Products and Ongoing Clinical Trials Overview 67
5.22 Fistulink Ltd. Company Overview 68
5.22.1 Fistulink Ltd. Pipeline Products and Ongoing Clinical Trials Overview 68
5.23 Flow Forward Medical, LLC Company Overview 69
5.23.1 Flow Forward Medical, LLC Pipeline Products and Ongoing Clinical Trials Overview 69
5.24 Fresenius Medical Care AG and Co. KGaA Company Overview 70
5.24.1 Fresenius Medical Care AG and Co. KGaA Pipeline Products and Ongoing Clinical Trials Overview 70
5.25 Fresenius Medical Care Holdings, Inc. Company Overview 76
5.25.1 Fresenius Medical Care Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 76
5.26 Georgia Institute of Technology Company Overview 78
5.26.1 Georgia Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 78
5.27 Glomeria Therapeutics Srl Company Overview 81
5.27.1 Glomeria Therapeutics Srl Pipeline Products and Ongoing Clinical Trials Overview 81
5.28 Healionics Corporation Company Overview 84
5.28.1 Healionics Corporation Pipeline Products and Ongoing Clinical Trials Overview 84
5.29 Laminate Medical Technologies Ltd. Company Overview 85
5.29.1 Laminate Medical Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 85
5.30 Marvao Medical Devices Limited Company Overview 88
5.30.1 Marvao Medical Devices Limited Pipeline Products and Ongoing Clinical Trials Overview 88
5.31 Medtronic plc Company Overview 91
5.31.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 91
5.32 Miromatrix Medical Inc. Company Overview 93
5.32.1 Miromatrix Medical Inc. Pipeline Products and Ongoing Clinical Trials Overview 93
5.33 Nanodialysis BV Company Overview 94
5.33.1 Nanodialysis BV Pipeline Products and Ongoing Clinical Trials Overview 94
5.34 NanoVasc, Inc. Company Overview 95
5.34.1 NanoVasc, Inc. Pipeline Products and Ongoing Clinical Trials Overview 95
5.35 Nicast Ltd. Company Overview 96
5.35.1 Nicast Ltd. Pipeline Products and Ongoing Clinical Trials Overview 96
5.36 NuVascular Technologies Inc Company Overview 97
5.36.1 NuVascular Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 97
5.37 NxStage Medical, Inc. Company Overview 99
5.37.1 NxStage Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 99
5.38 PeriTec Biosciences, Ltd. Company Overview 104
5.38.1 PeriTec Biosciences, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 104
5.39 Phase One Medical, LLC Company Overview 105
5.39.1 Phase One Medical, LLC Pipeline Products and Ongoing Clinical Trials Overview 105
5.40 qSTAR Medical SAS Company Overview 108
5.40.1 qSTAR Medical SAS Pipeline Products and Ongoing Clinical Trials Overview 108
5.41 Quanta Fluid Solutions Ltd. Company Overview 109
5.41.1 Quanta Fluid Solutions Ltd. Pipeline Products and Ongoing Clinical Trials Overview 109
5.42 RenalGuard Solutions, Inc. Company Overview 110
5.42.1 RenalGuard Solutions, Inc. Pipeline Products and Ongoing Clinical Trials Overview 110
5.43 Senexis Limited (Inactive) Company Overview 115
5.43.1 Senexis Limited (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 115
5.44 Surgical Specialties Corporation (Inactive) Company Overview 116
5.44.1 Surgical Specialties Corporation (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 116
5.45 TEI Biosciences, Inc. Company Overview 118
5.45.1 TEI Biosciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 118
5.46 Tengion, Inc. (Inactive) Company Overview 119
5.46.1 Tengion, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 119
5.47 University of California, San Francisco Company Overview 121
5.47.1 University of California, San Francisco Pipeline Products and Ongoing Clinical Trials Overview 121
5.48 University of Limerick Company Overview 124
5.48.1 University of Limerick Pipeline Products and Ongoing Clinical Trials Overview 124
5.49 Vanderbilt University Company Overview 125
5.49.1 Vanderbilt University Pipeline Products and Ongoing Clinical Trials Overview 125
5.50 Veryan Medical Limited Company Overview 127
5.50.1 Veryan Medical Limited Pipeline Products and Ongoing Clinical Trials Overview 127
5.51 Vital Access, Corp. Company Overview 128
5.51.1 Vital Access, Corp. Pipeline Products and Ongoing Clinical Trials Overview 128
5.52 Vivonics, Inc. Company Overview 129
5.52.1 Vivonics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 129
5.53 Vizio Medical Devices Company Overview 130
5.53.1 Vizio Medical Devices Pipeline Products and Ongoing Clinical Trials Overview 130
6 Renal Dialysis Equipment- Recent Developments 131
7 Appendix 205
7.1 Methodology 205
7.2 About GlobalData 207
7.3 Contact Us 208
7.4 Disclaimer 208

1.1 List of Figures
Table 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development 13
Table 2: Renal Dialysis Equipment - Pipeline Products by Segment 14
Table 3: Renal Dialysis Equipment - Pipeline Products by Territory 15
Table 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path 16
Table 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 17
Table 6: Renal Dialysis Equipment - Ongoing Clinical Trials 18
Table 7: Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development 19
Table 8: Renal Dialysis Equipment - Pipeline Products by Stage of Development 22
Table 9: 3S BioMedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
Table 10: Resorpor Hemodialysis Graft - Product Status 25
Table 11: Resorpor Hemodialysis Graft - Product Description 25
Table 12: Advanced Dialysis Methods Ltd. Pipeline Products and Ongoing Clinical Trials Overview 26
Table 13: Vibro-Care - Product Status 26
Table 14: Vibro-Care - Product Description 26
Table 15: AngioDynamics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 16: DuraFlow 2 VascPak - Product Status 28
Table 17: DuraFlow 2 VascPak - Product Description 28
Table 18: ARISTE Medical Pipeline Products and Ongoing Clinical Trials Overview 29
Table 19: Drug Eluting Tunneled Dialysis Catheter - Product Status 30
Table 20: Drug Eluting Tunneled Dialysis Catheter - Product Description 30
Table 21: Asahi Kasei Corporation Pipeline Products and Ongoing Clinical Trials Overview 31
Table 22: APS Polysulfone-membrane Artificial Kidney - New Version - Product Status 32
Table 23: APS Polysulfone-membrane Artificial Kidney - New Version - Product Description 32
Table 24: Hemodialysis Equipment - Product Status 33
Table 25: Hemodialysis Equipment - Product Description 33
Table 26: Ash Access Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
Table 27: MaxFlow - Product Status 34
Table 28: MaxFlow - Product Description 34
Table 29: SureFlow - Product Status 35
Table 30: SureFlow - Product Description 35
Table 31: AWAK Technologies Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview 36
Table 32: AWAK - Product Status 36
Table 33: AWAK - Product Description 36
Table 34: Baxter International Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 35: Gambro PDCATH - Self Locating Catheter - Product Status 38
Table 36: Gambro PDCATH - Self Locating Catheter - Product Description 38
Table 37: Non PVC CAPD - Product Status 39
Table 38: Non PVC CAPD - Product Description 39
Table 39: Serena APD Cycler - Product Status 40
Table 40: Serena APD Cycler - Product Description 40
Table 41: Theralite - Product Status 41
Table 42: Theralite - Product Description 41
Table 43: VIVIA Hemodialysis System - Product Status 42
Table 44: VIVIA Hemodialysis System - Product Description 42
Table 45: Baxter International Inc. - Ongoing Clinical Trials Overview 43
Table 46: VIVIA Hemodialysis System - A Study of Sleep Patterns in Patients Performing Nocturnal Home Dialysis Utilising the VIVIA System 44
Table 47: Theralite - An Open Label Phase II Trial of Free Light Chain Removal by Extended High Cut-Off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End-Stage Renal Disease 45
Table 48: Blood Purification Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 46
Table 49: Wearable Artificial Kidney - Product Status 46
Table 50: Wearable Artificial Kidney - Product Description 46
Table 51: CatheNect Medical Pipeline Products and Ongoing Clinical Trials Overview 47
Table 52: PD Catheter - Product Status 47
Table 53: PD Catheter - Product Description 47
Table 54: Chemica Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 55: Dialysis Regeneration Cartridge - Product Status 48
Table 56: Dialysis Regeneration Cartridge - Product Description 48
Table 57: Chrysalis Medical Weight Loss Clinic Pipeline Products and Ongoing Clinical Trials Overview 49
Table 58: Hemodialysis Catheter - Product Status 49
Table 59: Hemodialysis Catheter - Product Description 49
Table 60: Circuport, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
Table 61: Circuport System - Product Status 50
Table 62: Circuport System - Product Description 50
Table 63: Control Medical Technology, LLC Pipeline Products and Ongoing Clinical Trials Overview 51
Table 64: ASPIRE Hemodialysis - Product Status 51
Table 65: ASPIRE Hemodialysis - Product Description 51
Table 66: CreatiVasc Medical LLC Pipeline Products and Ongoing Clinical Trials Overview 52
Table 67: CreatiVasc Hemoaccess Valve System - Product Status 52
Table 68: CreatiVasc Hemoaccess Valve System - Product Description 52
Table 69: CreatiVasc Medical LLC - Ongoing Clinical Trials Overview 53
Table 70: CreatiVasc Hemoaccess Valve System - A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement 54
Table 71: Cytograft Tissue Engineering, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
Table 72: Lifeline TEBV - AV Shunt - Product Status 56
Table 73: Lifeline TEBV - AV Shunt - Product Description 56
Table 74: CytoPherx, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
Table 75: Selective Cytopheretic Device - Product Status 57
Table 76: Selective Cytopheretic Device - Product Description 57
Table 77: Debiotech S.A. Pipeline Products and Ongoing Clinical Trials Overview 58
Table 78: DialEase - Product Status 59
Table 79: DialEase - Product Description 59
Table 80: Miniaturized Home Hemodialysis Machine - Product Status 60
Table 81: Miniaturized Home Hemodialysis Machine - Product Description 60
Table 82: Renal Expres - Product Status 61
Table 83: Renal Expres - Product Description 61
Table 84: DEKA Research and Development Corporation Pipeline Products and Ongoing Clinical Trials Overview 62
Table 85: Amia Automated PD System With Sharesource - Product Status 63
Table 86: Amia Automated PD System With Sharesource - Product Description 63
Table 87: Dipylon Medical AB Pipeline Products and Ongoing Clinical Trials Overview 64
Table 88: CMA 60 Microdialysis Catheter - Product Status 65
Table 89: CMA 60 Microdialysis Catheter - Product Description 65
Table 90: Peripheral Microdialysis Pump Kit - Product Status 66
Table 91: Peripheral Microdialysis Pump Kit - Product Description 66
Table 92: ExThera Medical LLC. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 93: Seraph Blood Pump - Product Status 67
Table 94: Seraph Blood Pump - Product Description 67
Table 95: Fistulink Ltd. Pipeline Products and Ongoing Clinical Trials Overview 68
Table 96: Fistulink Device - Product Status 68
Table 97: Fistulink Device - Product Description 68
Table 98: Flow Forward Medical, LLC Pipeline Products and Ongoing Clinical Trials Overview 69
Table 99: AFE System - Product Status 69
Table 100: AFE System - Product Description 69
Table 101: Fresenius Medical Care AG and Co. KGaA Pipeline Products and Ongoing Clinical Trials Overview 70
Table 102: Mobile hospital Hemodialysis device - Product Status 71
Table 103: Mobile hospital Hemodialysis device - Product Description 71
Table 104: Wearable Artificial Kidney - Product Status 72
Table 105: Wearable Artificial Kidney - Product Description 72
Table 106: XCR-6 - Product Status 73
Table 107: XCR-6 - Product Description 73
Table 108: Fresenius Medical Care AG and Co. KGaA - Ongoing Clinical Trials Overview 74
Table 109: Wearable Artificial Kidney - First 24 Hour Human Trial of the Wearable Artificial Kidney 75
Table 110: Fresenius Medical Care Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 76
Table 111: Portable Artificial Kidney - Product Status 77
Table 112: Portable Artificial Kidney - Product Description 77
Table 113: Georgia Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 78
Table 114: KIDS CRRT - Product Status 79
Table 115: KIDS CRRT - Product Description 79
Table 116: Pediatric Renal Dialysis Machine - Product Status 80
Table 117: Pediatric Renal Dialysis Machine - Product Description 80
Table 118: Glomeria Therapeutics Srl Pipeline Products and Ongoing Clinical Trials Overview 81
Table 119: DesmoDK - Product Status 81
Table 120: DesmoDK - Product Description 81
Table 121: DesmoHD - Product Status 82
Table 122: DesmoHD - Product Description 82
Table 123: Smart Hemo - Product Status 83
Table 124: Smart Hemo - Product Description 83

1.2 List of Figures
Figure 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development 13
Figure 2: Renal Dialysis Equipment - Pipeline Products by Segment 14
Figure 3: Renal Dialysis Equipment - Pipeline Products by Territory 15
Figure 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path 16
Figure 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 17
Figure 6: Renal Dialysis Equipment - Ongoing Clinical Trials 18

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.